Andreas Maderna

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
THE CURATORS OF THE UNIVERSITY OF MISSOURI
1
2000
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
1
2008
PFIZER INC.
2
2
1
3
2012
2014
2015
2016
VALEANT RESEARCH & DEVELOPMENT
2
2008
ARDEA BIOSCIENCES, INC.
2
2
6
4
1
2
3
1
2006
2007
2008
2010
2011
2013
2014
2016
ITEOS THERAPEUTICS
2
2016
Andrea Biosciences, Inc.
1
2008
WYETH
1
2008

Inventor Addresses

AddressDuration
Escondido, CA, USNov 29, 18 - May 02, 24
Los Angeles, CADec 16, 03 - Dec 11, 08
Los Angeles, CA, USAug 31, 06 - Jan 26, 10
San Diego, CA, USSep 22, 16 - Jun 21, 22
South San Francisco, CA, USAug 04, 22 - Aug 04, 22
Stony Point, NYMar 06, 08 - Oct 16, 08
Stony Point, NY, USJul 20, 10 - Oct 02, 18
Tappan, NY, USMar 26, 09 - Mar 26, 09
WALNUT CREEK, CA, USFeb 22, 24 - Feb 22, 24
Walnut Creek, CA, USApr 06, 21 - Feb 18, 25

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 28
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 18
C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 2

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
122264902025Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class0
2025/0018,0542025ANTI-ROR1 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI ROR1 ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-ROR1 ANTIBODY CONJUGATES0
121448692024Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates0
2024/0139,2852024IMMUNOMODULATOR ANTIBODY DRUG CONJUGATES AND USES THEREOF0
2024/0091,3652024BETA-GLUCURONIDE LINKER-PAYLOADS, PROTEIN CONJUGATES THEREOF, AND METHODS THEREOF0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.